Sanitary and Phytosanitary Biotech Measures

Introduction

Sanitary and phytosanitary (SPS) measures are regulatory measures designed to protect human, animal, and plant health from risks arising from diseases, pests, contaminants, and harmful organisms. In biotechnology, SPS measures are particularly important for genetically modified organisms (GMOs), genetically modified crops, biotechnology-derived food, seeds, animal feed, and agricultural products.

These measures may include import restrictions, quarantine requirements, laboratory testing, risk assessments, certification, traceability, and approval procedures. Their purpose is to protect health and agriculture while ensuring that trade restrictions are scientifically justified.

The principal international legal framework is the World Trade Organization’s Agreement on the Application of Sanitary and Phytosanitary Measures (SPS Agreement). It seeks to balance the sovereign right of states to protect health with the obligation to avoid arbitrary or unjustified barriers to international trade.

Important Case Laws

1. European Communities — Measures Affecting the Approval and Marketing of Biotech Products, WTO, DS291, DS292 and DS293 (2006)

The United States, Canada, and Argentina challenged European Community measures concerning approval delays and national restrictions on genetically modified products. The WTO Panel found that the EC had applied a de facto moratorium on approvals between 1999 and 2003, resulting in undue delays contrary to Article 8 and Annex C of the SPS Agreement. It also found that certain member-state safeguard measures were inconsistent with Articles 2.2 and 5.1 because they were not based on adequate risk assessments.

DS291+1

The decision demonstrates that biotechnology-related SPS measures must be based on appropriate scientific risk assessment and must not create unjustified procedural delays. It did not establish that all GMO restrictions are unlawful.

2. India — Measures Concerning the Importation of Certain Agricultural Products, WTO, DS430 (2014)

The United States challenged Indian restrictions on agricultural imports, including measures relating to avian influenza. The WTO Panel found that India’s measures were inconsistent with several SPS Agreement provisions because they were not sufficiently supported by the relevant international standards and scientific risk assessment.

World Trade Organization

Although this dispute did not concern GMOs, it is relevant to biotechnology-derived agricultural products because it illustrates the importance of scientific justification, consistency with international standards, and proper risk assessment.

3. Japan — Measures Affecting Agricultural Products, WTO, DS76 (1999)

The dispute concerned Japanese restrictions on agricultural products and the requirement for testing different varieties. The WTO Appellate Body upheld the principle that SPS measures must be supported by a risk assessment and that testing requirements should be scientifically justified. This principle is relevant where countries require separate testing or approval for each biotechnology-derived crop variety.

Indian Legal Framework

India regulates biotechnology-related agricultural and food risks through several laws and authorities:

Environment (Protection) Act, 1986: Provides the basis for regulating genetically engineered organisms.

1989 Rules: Rules governing the manufacture, use, import, export, and storage of hazardous microorganisms and genetically engineered organisms or cells.

Food Safety and Standards Act, 2006: Regulates food safety, including applicable requirements for food products derived through biotechnology.

Plant Quarantine (Regulation of Import into India) Order, 2003: Provides phytosanitary requirements for importing plants and plant materials.

The relevant authorities may require risk assessment, testing, permits, quarantine, or other safeguards before import or release. Such measures must be administered under the applicable domestic law.

Principles Governing SPS Measures

A valid SPS measure should:

Be based on an assessment of the relevant health or agricultural risk.

Be supported by sufficient scientific evidence, subject to the SPS Agreement’s limited precautionary provision.

Avoid arbitrary or unjustifiable discrimination between countries where comparable conditions prevail.

Not operate as a disguised restriction on international trade.

Use a reasonably suitable measure where alternatives provide the required level of protection.

Maintain transparent and timely approval procedures.

These principles arise particularly under Articles 2, 5, 7 and 8 of the SPS Agreement and its annexes.

APEDA+1

Conclusion

Sanitary and phytosanitary biotechnology measures are essential for protecting human health, animal health, and plant life from risks associated with genetically modified organisms and biotechnology-derived agricultural products. However, such measures must be scientifically justified, proportionate, transparent, and consistent with international trade obligations.

The WTO disputes in EC — Approval and Marketing of Biotech Products and India — Agricultural Products demonstrate that countries may regulate biotechnology and agricultural imports, but they must support restrictive measures with appropriate risk assessments and comply with the SPS Agreement. The central legal principle is that the right to protect health must be exercised through evidence-based regulation rather than arbitrary trade restrictions.